Supernus announces merger with Indivior Pharmaceuticals
Supernus Pharmaceuticals and Indivior Pharmaceuticals have entered into a definitive merger agreement under which Supernus will acquire Indivior. The agreement was reached to combine the two specialty pharmaceutical companies.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day